Synonyms: compound 12d [PMID: 36692394] | SKLB03220
Compound class:
Synthetic organic
Comment: SKLB-03220 is reported as an orally bioavailable, covalent inhibitor of the histone methyltransferase, and oncology drug target, EZH2 [1]. Its chemical structure is based on that of the approved EZH2 inhibitor tazemetostat. SKLB-03220 abolishes epigenetic H3K27me3 marks.
![]() Ligand Activity Visualisation ChartsThese are box plot that provide a unique visualisation, summarising all the activity data for a ligand taken from ChEMBL and GtoPdb across multiple targets and species. Click on a plot to see the median, interquartile range, low and high data points. A value of zero indicates that no data are available. A separate chart is created for each target, and where possible the algorithm tries to merge ChEMBL and GtoPdb targets by matching them on name and UniProt accession, for each available species. However, please note that inconsistency in naming of targets may lead to data for the same target being reported across multiple charts. ✖ |
|
For advanced searching click here to open chemical structure editor